PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
1-Year Est. Return 13.3%
This Quarter Est. Return
1 Year Est. Return
+13.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.84B
AUM Growth
+$707M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1
+$140M
2
+$93.9M
3
+$84.7M
4
ARVN icon
Arvinas
ARVN
+$69.5M
5
TARS icon
Tarsus Pharmaceuticals
TARS
+$66.8M

Top Sells

1
+$90.7M
2
+$62M
3
+$41.8M
4
AUTL
Autolus Therapeutics
AUTL
+$39.5M
5
TGTX icon
TG Therapeutics
TGTX
+$37.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$23M 0.81%
+1,348,015
27
$21.9M 0.77%
+330,000
28
$19.9M 0.7%
2,390,988
+125,000
29
$15.3M 0.54%
6,457,293
30
$14.9M 0.52%
944,917
+544,917
31
$11.7M 0.41%
+400,000
32
$11.2M 0.39%
2,172,620
-751,231
33
$3.3M 0.12%
147,959
-185,374
34
$1.24M 0.04%
+50,000
35
– –
-4,092
36
– –
-2,171,419
37
– –
-1,091,779
38
– –
-4,352,689
39
– –
-1,543,116
1
2